Advanced Systemic Mastocytosis
4 clinical trials · Condition
◉ Watch Advanced Systemic Mastocytosis
| Record | Firm | Date |
|---|---|---|
| Retrospective Study Assessing the Effect of Avapritinib Versus Best Available Therapy in Patients With AdvSM (NCT04695431) | Blueprint Medicines Corporation | 2020-12-02 |
| (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis (NCT03580655) | Blueprint Medicines Corporation | 2018-11-21 |
| A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies (NCT02571036) | Deciphera Pharmaceuticals, LLC | 2015-11-01 |
Track Advanced Systemic Mastocytosis automatically
Every clearance here is in the API, with alerts when new ones post.